BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20938830)

  • 1. Denaturing HPLC for mutation screening.
    Mitchell M; Cutler J
    Methods Mol Biol; 2011; 688():17-33. PubMed ID: 20938830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography.
    Greiner TC
    Diagn Mol Pathol; 2007 Mar; 16(1):32-7. PubMed ID: 17471156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A versatile denaturing HPLC approach for human beta-globin gene mutation screening.
    Bournazos SN; Tserga A; Patrinos GP; Papadakis MN
    Am J Hematol; 2007 Feb; 82(2):168-70. PubMed ID: 16924651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
    Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
    J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of DNA polymerases on mutation screening of denaturing high-performance liquid chromatography].
    Liu MR; Pan KF; Wang Y; Lu YY
    Ai Zheng; 2002 Oct; 21(10):1160-3. PubMed ID: 12508666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis.
    Bénit P; Bonnefont JP; Kara Mostefa A; Francannet C; Munnich A; Ray PF
    Prenat Diagn; 2001 Apr; 21(4):279-83. PubMed ID: 11288117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of denaturing high performance liquid chromatography (DHPLC) for mutation scanning of hereditary cancer genes.
    Marsh DJ; Howell VM
    Methods Mol Biol; 2010; 653():133-45. PubMed ID: 20721741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denaturing HPLC-based approach for detection of COL7A1 gene mutations causing dystrophic epidermolysis bullosa.
    Posteraro P; Pascucci M; Colombi M; Barlati S; Giannetti A; Paradisi M; Mustonen A; Zambruno G; Castiglia D
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1391-401. PubMed ID: 16271705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF1 gene analysis based on DHPLC.
    De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
    Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHPLC screening of cystic fibrosis gene mutations.
    Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
    Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection.
    O'Donovan MC; Oefner PJ; Roberts SC; Austin J; Hoogendoorn B; Guy C; Speight G; Upadhyaya M; Sommer SS; McGuffin P
    Genomics; 1998 Aug; 52(1):44-9. PubMed ID: 9740670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in Salmonella enterica gyrA, gyrB, parC and parE genes by denaturing high performance liquid chromatography (DHPLC) using standard HPLC instrumentation.
    Randall LP; Coldham NG; Woodward MJ
    J Antimicrob Chemother; 2005 Oct; 56(4):619-23. PubMed ID: 16141278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
    Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
    Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a denaturing high-performance liquid chromatography screening method for SMAD4 in juvenile polyposis syndrome.
    Hatch SL; Trewick AL; Payne SJ
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):159-63. PubMed ID: 17362581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denaturing high-performance liquid chromatography for mutation detection and genotyping.
    Fackenthal DL; Chen PX; Das S
    Methods Mol Biol; 2005; 311():73-96. PubMed ID: 16100401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations.
    Meierhofer D; Mayr JA; Ebner S; Sperl W; Kofler B
    Mitochondrion; 2005 Aug; 5(4):282-96. PubMed ID: 16050991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.
    Colosimo A; Guida V; De Luca A; Cappabianca MP; Bianco I; Palka G; Dallapiccola B
    Hum Mutat; 2002 Mar; 19(3):287-95. PubMed ID: 11857746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denaturing high-performance liquid chromatography for mutation detection and genotyping.
    Fackenthal DL; Chen PX; Howe T; Das S
    Methods Mol Biol; 2013; 1015():25-54. PubMed ID: 23824847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography.
    Biggin A; Henke R; Bennetts B; Thorburn DR; Christodoulou J
    Mol Genet Metab; 2005 Jan; 84(1):61-74. PubMed ID: 15639196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid recognition of aberrant dHPLC elution profiles using the Transgenomic Navigator software.
    Colley J; Jones S; Dallosso AR; Maynard JH; Humphreys V; Dolwani S; Sampson JR; Cheadle JP
    Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.